{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T12:40:01Z","timestamp":1751114401421,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Mutations that alter the structure of red blood cells, including the mutations that cause sickle cell disease (SCD), are common globally because they protect against malaria. Patients with SCD rarely develop severe anemia that requires blood transfusions before 6 months of age. We present the case of a patient with SCD who developed severe anemia requiring a blood transfusion at 6 weeks old and subsequent transfusions throughout her first two and a half years of life. Next-generation sequencing genetic testing revealed that the patient also had hereditary pyropoikilocytosis (HPP), a severe form of hereditary elliptocytosis (HE), and was heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency. Following splenectomy, the frequency of her transfusions slightly decreased. This case demonstrates that HPP modifies the severity of SCD and highlights the importance of considering additional hematologic conditions and obtaining genetic testing in patients with SCD and early-onset anemia.<\/jats:p>","DOI":"10.1097\/mph.0000000000003012","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T21:00:16Z","timestamp":1741122016000},"page":"128-130","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary Pyropoikilocytosis as a Modifier of Sickle Cell Disease Severity"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6552-3668","authenticated-orcid":false,"given":"Megan","family":"Lantz","sequence":"first","affiliation":[{"name":"Saint Louis University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Dolatshahi","sequence":"additional","affiliation":[{"name":"Saint Louis University School of Medicine"},{"name":"SSM Health Cardinal Glennon Children\u2019s Hospital, St. Louis, MO"},{"name":"Department of Pediatric Hematology and Oncology, Saint Louis University, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"R1-20250628","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2010-01-261859","article-title":"The relationship between blood groups and disease","volume":"115","author":"Anstee","year":"2010","journal-title":"Blood"},{"key":"R2-20250628","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12936-015-0809-x","article-title":"The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?","volume":"14","author":"Lelliott","year":"2015","journal-title":"Malar J"},{"key":"R3-20250628","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"R5-20250628","first-page":"e11235","article-title":"Prevalence of glucose-6-phosphate dehydrogenase deficiency among children in Eastern Saudi Arabia","volume":"12","author":"Albagshi","year":"2020","journal-title":"Cureus"},{"key":"R8-20250628","doi-asserted-by":"crossref","first-page":"655","DOI":"10.12980\/APJTB.4.2014APJTB-2014-0100","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina Faso","volume":"4","author":"Ouattara","year":"2014","journal-title":"Asian Pac J Trop Biomed"},{"key":"R9-20250628","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2016.07.003","article-title":"Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis","volume":"61","author":"Niss","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"R10-20250628","doi-asserted-by":"crossref","first-page":"146796","DOI":"10.1016\/j.gene.2022.146796","article-title":"Unravelling the genetic and phenotypic heterogeneity of SPTA1 gene variants in hereditary elliptocytosis and hereditary pyropoikilocytosis patients using next-generation sequencing","volume":"843","author":"Anil More","year":"2022","journal-title":"Gene"},{"key":"R11-20250628","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/trf.17617","article-title":"Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis","volume":"64","author":"Brancamp","year":"2024","journal-title":"Transfusion"},{"key":"R12-20250628","doi-asserted-by":"crossref","first-page":"e27531","DOI":"10.1002\/pbc.27531","article-title":"Hereditary elliptocytosis-associated alpha-spectrin mutation p.L155dup as a modifier of sickle cell disease severity","volume":"66","author":"Risinger","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20250628","doi-asserted-by":"crossref","first-page":"3179173","DOI":"10.1155\/2019\/3179173","article-title":"Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices","volume":"2019","author":"Antwi-Baffour","year":"2019","journal-title":"Anemia"},{"key":"R14-20250628","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3923\/pjbs.2007.409.414","article-title":"Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso","volume":"10","author":"Simpore","year":"2007","journal-title":"Pak J Biol Sci"},{"key":"R15-20250628","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000209420","article-title":"Sickle cell disease and glucose-6-phosphate dehydrogenase","volume":"36","author":"Lewis","year":"1966","journal-title":"Acta Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T12:00:27Z","timestamp":1751112027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003012","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"type":"print","value":"1077-4114"},{"type":"electronic","value":"1536-3678"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"2024-09-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}